Paper910158
13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Grubbs CJ and 7 others. Science, 1977. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. Papers, record 910158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/910158
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Butylhydroxybutylnitrosamine | Major topic |
| Carcinoma, Transitional Cell | Major topic |
| Nitrosamines | Major topic |
| Tretinoin | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Vitamin A | Major topic |
| Animals | |
| Male | |
| Neoplasms, Experimental | |
| Rats | |
| Rats, Inbred F344 |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33805295 | Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33805295 | PubMed |
| 23272234 | In-frame cDNA library combined with protein complementation assay identifies ARL11-binding partners. | PLoS One | 2012 | https://conductscience.org/library/papers/23272234 | PubMed |
| 22028816 | Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model. | PLoS One | 2011 | https://conductscience.org/library/papers/22028816 | PubMed |
| 21924649 | When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression. | Urol Oncol | 2013 | https://conductscience.org/library/papers/21924649 | PubMed |
| 21139803 | Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models. | Am J Transl Res | 2010 | https://conductscience.org/library/papers/21139803 | PubMed |
| 18670642 | Molecular credentialing of rodent bladder carcinogenesis models. | Neoplasia | 2008 | https://conductscience.org/library/papers/18670642 | PubMed |
| 18497966 | Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers. | Oncol Rep | 2008 | https://conductscience.org/library/papers/18497966 | PubMed |
| 17401461 | Gene expression profiling of chemically induced rat bladder tumors. | Neoplasia | 2007 | https://conductscience.org/library/papers/17401461 | PubMed |
| 15548366 | Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine. | Neoplasia | 2004 | https://conductscience.org/library/papers/15548366 | PubMed |
| 7374366 | Vitamin A induced hypertriglyceridemia in cholesterol-fed rats. | Lipids | 1980 | https://conductscience.org/library/papers/7374366 | PubMed |
| 7036954 | Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetyl-aminofluorene mutagenesis in the Salmonella/microsome assay. | Arch Toxicol | 1982 | https://conductscience.org/library/papers/7036954 | PubMed |
| 7005246 | Cancer chemoprevention. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/7005246 | PubMed |
| 6235105 | Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. | Drugs | 1984 | https://conductscience.org/library/papers/6235105 | PubMed |
| 2924752 | Mechanisms of asbestos-induced squamous metaplasia in tracheobronchial epithelial cells. | Environ Health Perspect | 1989 | https://conductscience.org/library/papers/2924752 | PubMed |
| 363444 | Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology. | Experientia | 1978 | https://conductscience.org/library/papers/363444 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/910158
GET https://conductscience.org/api/papers/v1/910158/authors